Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2948 (LINC02948) is a human long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not encode a protein and does not overlap annotated protein-coding genes. LincRNAs, including LINC02948, have been shown to participate in a variety of gene regulatory and chromatin-related roles, such as remodeling chromatin, influencing genome architecture, stabilizing RNA, regulating transcription, and acting as enhancer-associated RNAs. While many lincRNAs have documented roles in fine-tuning gene expression—often with tissue-specificity—and several have been linked with disease, there are no known specific therapeutic drugs or targeted therapies, nor well-established disease associations, for LINC02948 at this time. LINC02948 is not considered a direct therapeutic target, receptor, enzyme, or transporter, and as with many lincRNAs, its precise biological function remains to be fully characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2948 (LINC02948).